These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7512287)

  • 21. Thiacetazone toxicity in the treatment of tuberculosis patients in Nigeria.
    Pearson CA
    J Trop Med Hyg; 1978 Dec; 81(12):238-42. PubMed ID: 85717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe hypersensitivity reactions among HIV-seropositive patients with tuberculosis treated with thioacetazone.
    Wkly Epidemiol Rec; 1992 Jan; 67(1-2):1-3. PubMed ID: 1371055
    [No Abstract]   [Full Text] [Related]  

  • 23. Rebuttal: time to call a halt to emotions in the assessment of thioacetazone.
    Rieder HL; Enarson DA
    Tuber Lung Dis; 1996 Apr; 77(2):109-11. PubMed ID: 8762843
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe cutaneous eruptions caused by thiacetazone used to treat tuberculosis in Rio Grande do Sul, Brazil. Public Health Dermatology Team, Tuberculosis Team, and Epidemiologic Control Unit, Rio Grande do Sul State Department of Health.
    Bull Pan Am Health Organ; 1981; 15(2):113-20. PubMed ID: 6173089
    [No Abstract]   [Full Text] [Related]  

  • 25. CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Boonyagars L; Hirunwiwatkul P; Hurst CP
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):338-344. PubMed ID: 28225346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study.
    Duncan LE; Elliott AM; Hayes RJ; Hira SK; Tembo G; Mumba GT; Ebrahim SH; Quigley M; Pobee JO; McAdam KP
    Trans R Soc Trop Med Hyg; 1995; 89(1):37-40. PubMed ID: 7747304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future.
    Lehloenya RJ; Dheda K
    Expert Rev Anti Infect Ther; 2012 Apr; 10(4):475-86. PubMed ID: 22512756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
    Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P
    J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.
    Johnson JL; Okwera A; Vjecha MJ; Byekwaso F; Nakibali J; Nyole S; Milberg J; Aisu T; Whalen CC; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):446-53. PubMed ID: 9441100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiacetazone skin reaction in Papua New Guinea.
    Naraqi S; Temu P
    Med J Aust; 1980 May; 1(10):480-1. PubMed ID: 6157976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Skin toxicity of thiacetazone (TB1) at a hospital service in Dakar].
    Dieng MT; Ndiaye B; Camara C
    Dakar Med; 2001; 46(1):1-3. PubMed ID: 15773145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiacetazone--avoid like poison or use with care?
    Nunn P; Porter J; Winstanley P
    Trans R Soc Trop Med Hyg; 1993; 87(5):578-82. PubMed ID: 7505496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of thiacetazone.
    Wilkinson D; Moore D
    Lancet; 1995 Jan; 345(8941):63. PubMed ID: 7528313
    [No Abstract]   [Full Text] [Related]  

  • 34. Thiacetazone reactions.
    Munthali MM; Warndoff DK; Koka CW; Glynn JR; Salaniponi FL
    Trans R Soc Trop Med Hyg; 1995; 89(2):238. PubMed ID: 7539955
    [No Abstract]   [Full Text] [Related]  

  • 35. Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions.
    Lehloenya RJ; Todd G; Badri M; Dheda K
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1649-57. PubMed ID: 22118173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexistence of fixed drug eruptions and Stevens Johnson syndrome due to thiacetazone in a patient of pulmonary tuberculosis.
    Gupta PK; Luniya AK; Gupta NK; Tiwari ML
    Indian J Chest Dis Allied Sci; 1983; 25(2):152-4. PubMed ID: 6197367
    [No Abstract]   [Full Text] [Related]  

  • 37. Trends in childhood tuberculosis in Zambia: a situation analysis.
    Kapata N; Chanda-Kapata P; O'Grady J; Bates M; Mwaba P; Janssen S; Marais B; Cobelens F; Grobusch M; Zumla A
    J Trop Pediatr; 2013 Apr; 59(2):134-9. PubMed ID: 23243079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic review: tuberculosis.
    Houston S; Pozniak A; Ray CS
    Cent Afr J Med; 1991 Aug; 37(8):250-9. PubMed ID: 1807799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa.
    Floyd K; Wilkinson D; Gilks C
    BMJ; 1997 Nov; 315(7120):1407-11. PubMed ID: 9418087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of tuberculosis in developing countries.
    Elliott AM; Mwinga AG; Foster SD
    Lancet; 1995 Oct; 346(8982):1098-9. PubMed ID: 7564805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.